Marvin Boris, MD

Articles by Marvin Boris, MD

Persistence of Lymphedema Reduction After Noninvasive Complex Lymphedema Therapy

January 1st 1997

We treated 119 consecutive patients with lymphedema with complex lymphedema therapy (CLT). Lymphedema reductions after CLT averaged 62.6% in the 56 patients with one affected arm and 68.6% in the 38 patients with

Latest Updated Articles

Persistence of Lymphedema Reduction After Noninvasive Complex Lymphedema Therapy
Published: January 1st 1997 | Updated:

Marvin Boris, MD

Articles by Marvin Boris, MD

Persistence of Lymphedema Reduction After Noninvasive Complex Lymphedema Therapy

Latest Updated Articles

Trending on CancerNetwork

FDA OKs Subcutaneous Daratumumab in High-Risk Smoldering Multiple Myeloma

Evaluating the Viability of Antibody Drug Conjugates for Glioblastoma

Daratumumab Approval May Be “Game Changer” in High-Risk Smoldering Myeloma

What Do Physicians and Patients Think About ADCs as Cancer Treatment?

FDA Approves Abbreviated NDA for Dasatinib Tablets in Leukemia Indications